3-Acetyl-2,5-dimethylfuran
Common Name: |
3-Acetyl-2,5-dimethylfuran |
IUPAC Name: |
1-(2,5-dimethylfuran-3-yl)ethanone |
Molecular Formula: |
C8H10O2 |
SMILES: |
CC1=CC(=C(O1)C)C(=O)C |
Inchi: |
1S/C8H10O2/c1-5-4-8(6(2)9)7(3)10-5/h4H,1-3H3 |
Inchi Key: |
KBSVBCHYXYXDAG-UHFFFAOYSA-N |
Cas No: |
10599-70-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
138.16 |
Mass (g/mol) |
138.068 |
Molar Refractivity |
38.83 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
30.21 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
83.00 @ 11.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.014 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.38 |
LogP |
2.099 |
iLOGP |
2.01 |
XLOGP3 |
1.47 |
WLOGP |
2.10 |
MLOGP |
0.51 |
ESOL Log S |
-1.93 |
ESOL Solubility (mg/ml) |
1.64 |
ESOL Solubility (mol/l) |
0.012 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.71 |
Ali Solubility (mg/ml) |
2.69 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.69 |
Silicos-IT Solubility (mg/ml) |
0.28 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.10 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.774 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.342 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |